| Literature DB >> 27887890 |
Jamie L Betker1, Thomas J Anchordoquy2.
Abstract
Repetitive administration is routinely used to maintain therapeutic drug levels, but previous studies have documented an accelerated blood clearance of some lipid-based delivery systems under these conditions. To assess the effect of repetitive administration, non-PEGylated lipoplexes (+/-0.5) were administered 4 times via tail vein injection at 3-day intervals to immunocompetent BALB/c mice bearing 4T1 tumors. This study measured the effect of repeat administration of nontargeted lipoplexes on clearance, cytokine/chemokine response, plasmid distribution, reporter gene expression, and liver toxicity. We do not observe a refractory period or a statistically significant difference in blood clearance between the first administration and subsequent injections of this lipoplex formulation, consistent with the absence of a cytokine/chemokine response. However, we do see a significant effect on both plasmid accumulation and expression, an enhancement of 26-fold and 10-fold in tumor plasmid levels and expression, respectively, after 4 injections as compared to that after a single injection. In addition, in vivo imaging suggests that expression in other organs had diminished rapidly 72 h after each administration, in contrast to relatively constant expression in the tumor. Taken together, the findings indicate that gene delivery to tumors can be dramatically enhanced by employing repetitive administration.Entities:
Keywords: biodistribution; cholesterol nanodomain; clearance; gene delivery; immunocompetent; lipoplex; liver toxicity; refractory period; repeat dosing; sphingosine
Mesh:
Substances:
Year: 2016 PMID: 27887890 PMCID: PMC5657239 DOI: 10.1016/j.xphs.2016.11.013
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.534